🚀 Durchbruch bei Novartis: Ihre neue Radioligandentherapie (RLT) bekämpft Krebs gezielt und zeigte in Studien eine Krebsheilung bei bis zu 21% der Patienten. Ein Hoffnungsschimmer für die Zukunft der Krebsbehandlung! 🎗️🧬 #CancerBreakthrough #Novartis #RadioligandTherapy https://www.watson.ch/wirtschaft/gesundheit/257419161-durchbruch-bei-neuer-novartis-krebstherapie
Durchbruch bei neuer Novartis-Krebstherapie

Eine neue Krebstherapie von Novartis hat bei Ärztinnen und Forschenden für euphorische Reaktionen gesorgt.

watson

#ProstateCancer: Doctors excited about forthcoming therapy https://www.ctvnews.ca/health/doctors-excited-about-targeted-prostate-cancer-therapy-but-can-t-prescribe-it-yet-1.6953950#RLT works by finding a target, which is usually a receptor on the surface of cancer cells..

#RadioligandTherapy depends on identifying that receptor in each patient's cancer cells using a #PETscan, then delivering the right radioactive medication — like Pluvicto for prostate cancer and Lutathera for neuroendocrine tumours — that will bind to the cancer cells and kill them without harming healthy cells”

Doctors excited about targeted prostate cancer therapy, but can't prescribe it yet

Oncologists say radioligand therapy, or RLT, is poised to become a new "pillar" of cancer care, alongside surgery, chemotherapy and radiation.

CTVNews
New wave of radioligand therapy triggers Belgium to launch action plan

A new wave of radioligand therapies is approaching. With healthcare systems and policymakers ill-equipped to h

EURACTIV